Navigation Links
Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
Date:11/14/2007

PT. RICHMOND, Calif., Nov. 14 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Thomas P. Soloway, Senior Vice President and Chief Financial Officer, will present at the 19th Annual Piper Jaffray Health Care Conference at the Pierre Hotel in New York City on Tuesday, November 27, 2007 at 10:30 AM Eastern Time.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. Transcept development projects leverage new understanding of CNS conditions to provide additional uses and enhanced clinical benefits for existing active agents. The lead Transcept product, Intermezzo(R) (zolpidem tartrate lozenge), is a low dose sublingual formulation of zolpidem that is currently in late phase 3 clinical trials for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep. Another product being developed by Transcept is TO-2060, a novel, fixed-dose combination of olanzapine and ondansetron for the treatment of dopamine associated psychiatric disorders. TO-2060 is currently the subject of an initial proof of concept trial in the treatment of alcohol use disorder. For more information, please visit the company's website at: http://www.transcept.com.

Contacts:

Transcept Pharmaceuticals, Inc. The Ruth Group

Michael Gill, Investors / Media

Director of Communications Stephanie Carrington / Jason Rando

(510) 215-3575 (646) 536-7017 / 7025

mgill@transcept.com scarrington@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
2. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ood, wing shapes changed rapidly, researchers say ... Many people think evolution takes hundreds, if no...er and new research shows exactly how: The simple ...g an effect on a population of birds. , Resear...ine edition of Current Biology , said a single po...
(Date:12/3/2009)... 3 According to the World Health O...Swine Flu") has reached a pandemic level. Over 50...least 6,500 fatalities. Since there is no longer ... these numbers undoubtedly understate the real sit...gi-bin/prnh/20091203/NY20654 ) ,, There are cu...
(Date:12/3/2009)..., PARSIPPANY, N.J. and ANDOVER, Mass., Dec. 3 /PRN...mage Intelligence® company, and Visage Imagin...icus Ltd. (ASX: PME) announced today that they hav...d market advanced oncology solutions for the clini...nership enables Definiens to utilize the Visage...
(Date:12/3/2009)...PRNewswire/ -- An exciting treatment gaining accep...latelet-rich plasma therapy (PRP), is showing stro...lant procedures, according to a prominent dental r...ntology . ,, James Rutkowski, DMD, PhD, repor... American Academy of Implant Dentistry that platel...
(Date:12/3/2009)...1,500 Jobs Listed through APHA,s Public Health Car...SNewswire/ -- Today,s White House jobs summit refl... professions, including public health. One public ...t job seekers to more than 1,500 jobs in the healt.../www.apha.org/about/careers/ is a full online car...
Breaking Medicine News(10 mins):Health News:Feeding Birds in Winter Could Speed Evolution of Species 2Health News:Buchang Global Health Forum 2009: An Innovative Approach for Management of H1N1 Swine Flu 2Health News:Visage Imaging and Definiens Announce Partnership 2Health News:Visage Imaging and Definiens Announce Partnership 3Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2Health News:Public Health Jobs Site Available to Help Meet Growing Demand 2
...ding to researchers at the University of Vermont i...ntain a balance between over inflation and under i... pumped in to the lungs then it will result in the...tect against VILI. But low tidal volumes can lead ...
...nd AIDS infections have shown a sharp rise in Jamm... have shot up from two in 1999 to 745 now, reports...ies in a low prevalence risk zone, with an infecti...ons of migrant labourers, truck drivers, security ...
...esearchers of the University of Queensland carried...ital in Brisbane. They reported that Spray –on ski... victims. “Microskin” is the product that not...spray-on skin technology, adheres to the epidermis...
...o probe has been developed by Georgia Tech researc...lls communicates with other cells and reacts //to ...ng it. This would help to better create drugs that...suffer from significant deficiencies. Typically, t...
...ease called Onchocerciasis, river blindness or cra...ea. The disease presents as a weakening// in affec...ot fit for work. This in turn adversely impacts th...viromental conditions such as humidity, rapid wate...
...dy published by scientists from California Univers... treatment needs re-evaluation//. Scientist have ...iretroviral therapy (ARV) by hiding in intestinal ...king. Professor Satya Dandekar, head of the...
Other Medicine News:Health News:Too Much of Air in the Lungs Results in VILI 2Health News:Too Much of Air in the Lungs Results in VILI 3Health News:Too Much of Air in the Lungs Results in VILI 4Health News:HIV/AIDS on Rise in Jammu and Kashmir 2Health News:Cell Behavior Better Understood with Nano Probe 2Health News:Cell Behavior Better Understood with Nano Probe 3Health News:Onchocerciasis: Presentation And Treatment 2
(Date:12/3/2009)...D, Mass., Dec. 3 MicroCHIPS, a dev... today announced it has been named a 2010 Technolo...e company was selected for pioneering a novel medi... implants designed to bridge the gap between disea...gies have broad applicability, from ,rescue, appli...
(Date:12/3/2009)...BURG, Pa., Dec. 3 New s...rocessing company build a new cold storage facilit...or expand operations while creating at least 20 jo..., The Pennsylvania Industrial Development Author...three projects. The investments, in the form of lo...
(Date:12/3/2009)... NANJING, China, Dec. 3 /PRNewswire-Asia/ -- Sim...ny") (NYSE: SCR ), a leading pharmaceutical comp..., and marketing of branded,generic and proprietary...na,s,State Food and Drug Administration ("SFDA") h...ality issues regarding human use rabies vaccine (v...
Breaking Medicine Technology:MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum 2Governor Rendell: New State Investments Bear Fruit in Adams County; Help Pharmaceutical Company Expand in Philadelphia 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Research Based Biopharmaceutical Company Awards Trials to DATATRAK 4891 1Research Based Biopharmaceutical Company Awards Trials to DATATRAK 4891 2Research Based Biopharmaceutical Company Awards Trials to DATATRAK 4891 3Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 1Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 2Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 3Vtech 28R 29 Delivers Todays Hottest Trends to Tech Savvy Kids 4890 1Vtech 28R 29 Delivers Todays Hottest Trends to Tech Savvy Kids 4890 2Vtech 28R 29 Delivers Todays Hottest Trends to Tech Savvy Kids 4890 3Vtech 28R 29 Delivers Todays Hottest Trends to Tech Savvy Kids 4890 4
M2a-Taper RingLoc Liner
Ascent Primary Knee System - Ascent/Maxim CoCr I-Beam Tibial Tray
...nee offers a femoral option and tibial insert whic...gages at 60 degrees of flexion to induce a smooth ...degrees of flexion. Femoral component comes in a P...e constrained tibial insert in conjunction with th...
ADVANCE Posterior Stabilized Total Knee Systems
Medicine Products: